Developer docs
API playgroundTry for free, no card

Search company profiles

Rabble Health

Full company profile

uuid0006sa9

Namestring
Rabble Health
Legal namestring
Rabble Health, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Rabble Health, Inc. is a California-based digital health company that builds a platform ecosystem for patient engagement across the cancer care continuum and adjacent conditions. The company operates three product lines: myRabble, a patient-facing decision and support platform that helps patients understand their condition, navigate treatment decisions, and track milestones, symptoms, and therapy adherence; Monarch, an insights and analytics platform serving as a data integration layer that enables healthcare clients to launch initiatives and capture real-world patient and provider insights within weeks; and ClinEx, a clinical decision and support platform for healthcare providers (listed as 'coming soon') designed to simplify complex diagnoses and shared decision-making using patient input and clinical guidelines. The company explicitly positions its solutions around reducing patient drop-off between symptom recognition, diagnosis, treatment access, and ongoing care.

The business operates across multiple customer segments with hybrid segmentation. Primary segments are life sciences companies (pharmaceutical and biotech firms seeking patient activation, clinical trial optimization, and real-world evidence generation) and patient advocacy organizations (nonprofits seeking to expand digital reach and connect patients to support services). Secondary segments are individual patients and caregivers (consumers accessing myRabble directly) and healthcare providers (future ClinEx users). The company has built a partnership network of ten advocacy and nonprofit organizations spanning oncology, respiratory, caregiver, and health equity domains, which functions as both a distribution channel and a community co-creation mechanism. Distribution spans direct enterprise field sales, B2B2C embedded deployment through life sciences clients, and direct-to-consumer self-serve access through myrabble.com. The company is founder-led by Aubrey Kelly, who created Rabble Health following personal experience as a caregiver to her son during treatment for a rare blood cancer, and who previously held roles in clinical trials, life sciences commercialization, and strategic partnerships.

Revenue mechanics span three streams: recurring platform subscriptions to life sciences and healthcare organizations (myRabble and Monarch access), professional services including patient activation initiatives, patient choice mapping, insights research, and patient-reported performance measurement, and managed services for patient community engagement and co-creation orchestration. Pricing is not publicly disclosed; enterprise contracts are individually scoped. The company holds HIPAA Business Associate status with documented safeguards for PHI handling, which is required for enterprise contracting with life sciences and healthcare buyers. Geographic footprint is domestic United States only. No funding rounds, named enterprise customer logos, or revenue figures are publicly disclosed, and the company appears to operate with a small employee base.

Short descriptiontext

Rabble Health is a California-based digital health company that builds patient engagement and analytics platforms (myRabble, Monarch, and forthcoming ClinEx) to reduce care drop-off for life sciences companies, patient advocacy organizations, providers, and patients, primarily in oncology and adjacent conditions across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersThousand Oaks, United States
HQ citystring
Thousand Oaks
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital patient engagement, cancer care coordination, clinical decision support, real-world evidence platform, patient activation software
Industry3 codes
PRIMARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code3 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code2 codes
  • Services-Health Services8000
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Digital Health Patient Engagement Platforms
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Platform Subscriptions for Life Sciences
TypeSubscription Recurring
Description

Rabble Health appears to offer platform access and services to life sciences companies and healthcare organizations on a subscription basis, with their platforms (myRabble, Monarch) being offered as ongoing services to enterprise clients.

rabblehealth.com
2Consulting & Implementation Services
TypeProfessional Services
Description

Consulting and implementation services including patient activation initiatives, patient choices mapping, patient insights research, and patient reported performance measurement for pharmaceutical and healthcare clients.

rabblehealth.com
3Patient Community & Engagement Services
TypeManaged Services
Description

Managed patient community engagement and co-creation collaboration services, including orchestration of collaboration sessions to identify opportunities and activations across the healthcare experience.

rabblehealth.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1myRabble
Description

Patient Decision & Support Platform that helps patients understand their condition, navigate treatment decisions, and stay engaged in care. Tracks milestones, symptoms, and progress to support starting and staying on therapy.

rabblehealth.com
+2 more records
Core offering1 text field

Rabble Health operates a multi-platform digital health ecosystem comprising myRabble (a patient decision and support platform that helps patients understand conditions, navigate treatment decisions, and track milestones and symptoms), Monarch (an insights and analytics platform that serves as a data integration layer to capture real-world evidence within weeks), and ClinEx (a clinical decision support platform for healthcare providers, coming soon). These platforms are designed to reduce patient drop-off across the cancer and chronic disease care journey and are sold primarily to life sciences companies, healthcare organizations, and patient advocacy organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Real-world insights captured within weeks rather than months
+1 more record
Product overview1 text field

Rabble Health offers a multi-platform digital health ecosystem comprising three core products: myRabble (patient-facing decision and support platform for navigating treatment and staying engaged in care), Monarch (insights and analytics platform providing data integration and real-world evidence capture), and ClinEx (clinical decision support platform for healthcare providers to navigate complex diagnoses and shared decision making). These platforms are designed to reduce patient drop-off across the care journey from symptom recognition through diagnosis, treatment access, and ongoing care.

Product and service3 records
1myRabble
CategoryPatient Engagement Software
Description

Patient Decision & Support Platform that helps patients understand their condition, navigate treatment decisions, and stay engaged in care. Tracks milestones, symptoms, and progress to support starting and staying on therapy. Used by individual patients and caregivers directly, and deployed by life sciences companies and healthcare organizations for patient activation.

2Monarch
CategoryHealthcare Analytics Software
Description

Insights & Analytics Platform serving as a data integration layer that enables healthcare clients to launch initiatives quickly while capturing real-world insights from patients and providers. Collects impact, outcomes, and care experience measures within weeks, not months. Sold to life sciences companies and healthcare organizations for real-world evidence generation and product lifecycle management.

3ClinEx
CategoryClinical Decision Support Software
Description

Clinical Decision & Support Platform (coming soon) that helps healthcare providers navigate complex diagnoses and treatment decisions using patient input and clinical guidelines. Simplifies care pathways and shared decision making for healthcare providers including physicians, nurses, and care coordinators.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1American Cancer Society (ACS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to improve patient access to testing and treatment options. Collaborating to create greater impact in cancer care through patient education and support services.

rabblehealth.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to expand reach and patient support for asthma and allergy patients, ensuring resources are accessible to those who need them.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to support cancer survivors through improved digital resources and patient activation initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to provide digital support resources and expand reach for young adult cancer patients and survivors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to improve cancer-related legal and practical support resources accessibility for patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to enhance breast cancer patient education, support, and advocacy resources through digital channels.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership to improve access to affordable medications and healthcare resources for patients through resource sharing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to support caregivers with resources and tools to better navigate patient care journeys.

9Carin' and Sharin'
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to expand caregiver support networks and share resources across the patient community.

rabblehealth.com
10AHIS (African Health Information Systems)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to improve health information access and patient support within African American communities.

rabblehealth.com
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Cure Forward is a patient engagement platform focused on connecting cancer patients to clinical trials and treatment information. It overlaps with Rabble's oncology patient education and clinical trial recruitment capabilities but with a narrower scope.

TypeBroad incumbent
Description

PatientPoint is a leading patient engagement platform focused on point-of-care education and communication. It shares the patient engagement and education thesis with myRabble, though it is anchored to clinical settings rather than the full care journey.

TypeDirect peer
Description

Navigating Cancer provides a patient-facing platform for oncology symptom management, treatment adherence, and care coordination, with a direct-to-patient and provider model. It is the closest pure-oncology analog to myRabble's cancer-care engagement focus.

TypeDirect peer
Description

Signant Health provides patient engagement, eCOA, and real-world evidence solutions for clinical trials and commercial pharma. It directly overlaps with Rabble's myRabble and Monarch platforms in serving life sciences with patient-centric data and engagement tooling.

TypeEmerging player
Description

Castor offers a decentralized clinical trial platform with eConsent, eCOA, and patient engagement features. It is comparable to Rabble's Monarch/myRabble combination for clinical trial sponsors but focused on the trial-conduct stage rather than commercial lifecycle.

TypeBroad incumbent
Description

IQVIA is a global CRO and RWE leader offering patient engagement, real-world data, and commercial services to life sciences. It is a broad incumbent whose patient engagement and RWE offerings compete with Rabble's enterprise life sciences GTM.

TypeDirect peer
Description

Evidation Health operates a direct-to-patient platform for real-world health data and engagement, partnering with life sciences for RWE and outcomes research. Like Rabble, it captures consented longitudinal data from patients and feeds insights to pharma.

TypeBroad incumbent
Description

Health Catalyst is a healthcare data and analytics platform providing real-world data and outcomes measurement to providers and life sciences. It is a broad incumbent competitor to Monarch's RWE and outcomes analytics positioning.

TypeBroad incumbent
Description

Medidata is the largest clinical trial technology platform, offering patient engagement, RWE, and decentralized trial capabilities. It competes with Rabble for pharma RWE and trial optimization budgets at a much larger scale and broader portfolio.

10TrialCard
TypeDirect peer
Description

TrialCard (now part of Pharmaceutical Product Development) provides patient access, adherence and engagement solutions for pharma. It directly overlaps with myRabble's therapy adherence and patient activation capabilities for life sciences clients.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rabble Health

Digital Health Patient Engagement Platformsrabblehealth.com

Rabble Health is a California-based digital health company that builds patient engagement and analytics platforms (myRabble, Monarch, and forthcoming ClinEx) to reduce care drop-off for life sciences companies, patient advocacy organizations, providers, and patients, primarily in oncology and adjacent conditions across the United States.

What Rabble Health does

Rabble Health, Inc. is a California-based digital health company that builds a platform ecosystem for patient engagement across the cancer care continuum and adjacent conditions. The company operates three product lines: myRabble, a patient-facing decision and support platform that helps patients understand their condition, navigate treatment decisions, and track milestones, symptoms, and therapy adherence; Monarch, an insights and analytics platform serving as a data integration layer that enables healthcare clients to launch initiatives and capture real-world patient and provider insights within weeks; and ClinEx, a clinical decision and support platform for healthcare providers (listed as 'coming soon') designed to simplify complex diagnoses and shared decision-making using patient input and clinical guidelines. The company explicitly positions its solutions around reducing patient drop-off between symptom recognition, diagnosis, treatment access, and ongoing care.

The business operates across multiple customer segments with hybrid segmentation. Primary segments are life sciences companies (pharmaceutical and biotech firms seeking patient activation, clinical trial optimization, and real-world evidence generation) and patient advocacy organizations (nonprofits seeking to expand digital reach and connect patients to support services). Secondary segments are individual patients and caregivers (consumers accessing myRabble directly) and healthcare providers (future ClinEx users). The company has built a partnership network of ten advocacy and nonprofit organizations spanning oncology, respiratory, caregiver, and health equity domains, which functions as both a distribution channel and a community co-creation mechanism. Distribution spans direct enterprise field sales, B2B2C embedded deployment through life sciences clients, and direct-to-consumer self-serve access through myrabble.com. The company is founder-led by Aubrey Kelly, who created Rabble Health following personal experience as a caregiver to her son during treatment for a rare blood cancer, and who previously held roles in clinical trials, life sciences commercialization, and strategic partnerships.

Revenue mechanics span three streams: recurring platform subscriptions to life sciences and healthcare organizations (myRabble and Monarch access), professional services including patient activation initiatives, patient choice mapping, insights research, and patient-reported performance measurement, and managed services for patient community engagement and co-creation orchestration. Pricing is not publicly disclosed; enterprise contracts are individually scoped. The company holds HIPAA Business Associate status with documented safeguards for PHI handling, which is required for enterprise contracting with life sciences and healthcare buyers. Geographic footprint is domestic United States only. No funding rounds, named enterprise customer logos, or revenue figures are publicly disclosed, and the company appears to operate with a small employee base.

Rabble Health firmographics

Firmographics
Name
Rabble Health
Legal name
Rabble Health, Inc.
Website
https://rabblehealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Rabble Health is a California-based digital health company that builds patient engagement and analytics platforms (myRabble, Monarch, and forthcoming ClinEx) to reduce care drop-off for life sciences companies, patient advocacy organizations, providers, and patients, primarily in oncology and adjacent conditions across the United States.
Ownership category
akta.pro rank

Rabble Health industry classification

Industry
Product category
Digital Health Patient Engagement Platforms
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital patient engagement
  • Cancer care coordination
  • Clinical decision support
  • Real-world evidence platform
  • Patient activation software

Where Rabble Health is headquartered

Location

Headquarters

HQ city
Thousand Oaks
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rabble Health business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform Subscriptions for Life Sciences: Rabble Health appears to offer platform access and services to life sciences companies and healthcare organizations on a subscription basis, with their platforms (myRabble, Monarch) being offered as ongoing services to enterprise clients.
  2. Consulting & Implementation Services: Consulting and implementation services including patient activation initiatives, patient choices mapping, patient insights research, and patient reported performance measurement for pharmaceutical and healthcare clients.
  3. Patient Community & Engagement Services: Managed patient community engagement and co-creation collaboration services, including orchestration of collaboration sessions to identify opportunities and activations across the healthcare experience.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Rabble Health product offering

Product offering

Core offering

Rabble Health operates a multi-platform digital health ecosystem comprising myRabble (a patient decision and support platform that helps patients understand conditions, navigate treatment decisions, and track milestones and symptoms), Monarch (an insights and analytics platform that serves as a data integration layer to capture real-world evidence within weeks), and ClinEx (a clinical decision support platform for healthcare providers, coming soon). These platforms are designed to reduce patient drop-off across the cancer and chronic disease care journey and are sold primarily to life sciences companies, healthcare organizations, and patient advocacy organizations.

Product overview

Rabble Health offers a multi-platform digital health ecosystem comprising three core products: myRabble (patient-facing decision and support platform for navigating treatment and staying engaged in care), Monarch (insights and analytics platform providing data integration and real-world evidence capture), and ClinEx (clinical decision support platform for healthcare providers to navigate complex diagnoses and shared decision making). These platforms are designed to reduce patient drop-off across the care journey from symptom recognition through diagnosis, treatment access, and ongoing care.

Differentiator

Problem solved

Functional benefit

Brands

  • myRabble: Patient Decision & Support Platform that helps patients understand their condition, navigate treatment decisions, and stay engaged in care. Tracks milestones, symptoms, and progress to support starting and staying on therapy.
  • Monarch
  • ClinEx

Products and services

  • myRabble Patient Decision & Support Platform that helps patients understand their condition, navigate treatment decisions, and stay engaged in care. Tracks milestones, symptoms, and progress to support starting and staying on therapy. Used by individual patients and caregivers directly, and deployed by life sciences companies and healthcare organizations for patient activation.
  • Monarch Insights & Analytics Platform serving as a data integration layer that enables healthcare clients to launch initiatives quickly while capturing real-world insights from patients and providers. Collects impact, outcomes, and care experience measures within weeks, not months. Sold to life sciences companies and healthcare organizations for real-world evidence generation and product lifecycle management.
  • ClinEx Clinical Decision & Support Platform (coming soon) that helps healthcare providers navigate complex diagnoses and treatment decisions using patient input and clinical guidelines. Simplifies care pathways and shared decision making for healthcare providers including physicians, nurses, and care coordinators.

Quantifiable outcome

  • Real-world insights captured within weeks rather than months
  • +1 more outcomes

Companies that use Rabble Health

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Rabble Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Rabble Health partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • American Cancer Society (ACS)coreStrategic or Co-development PartnerPartnership to improve patient access to testing and treatment options. Collaborating to create greater impact in cancer care through patient education and support services.
  • Asthma and Allergy Foundation of America (AAFA)coreStrategic or Co-development PartnerPartnership to expand reach and patient support for asthma and allergy patients, ensuring resources are accessible to those who need them.
  • National Coalition for Cancer Survivorship (NCCS)coreStrategic or Co-development PartnerCollaboration to support cancer survivors through improved digital resources and patient activation initiatives.
  • Cactus Cancer SocietycoreStrategic or Co-development PartnerPartnership to provide digital support resources and expand reach for young adult cancer patients and survivors.
  • Triage CancercoreStrategic or Co-development PartnerCollaboration to improve cancer-related legal and practical support resources accessibility for patients.
  • Breast Cancer CoalitioncoreStrategic or Co-development PartnerPartnership to enhance breast cancer patient education, support, and advocacy resources through digital channels.
  • NeedyMedsminorGTM or Marketing PartnerPartnership to improve access to affordable medications and healthcare resources for patients through resource sharing.
  • Caregivers reFresh CentercoreStrategic or Co-development PartnerPartnership to support caregivers with resources and tools to better navigate patient care journeys.
  • Carin' and Sharin'coreStrategic or Co-development PartnerPartnership to expand caregiver support networks and share resources across the patient community.
  • AHIS (African Health Information Systems)coreStrategic or Co-development PartnerPartnership to improve health information access and patient support within African American communities.

Scale indicators3 records

Recent moves1 record

Expansion highlights6 records

Rabble Health competitors and assessment

Company assessment

Emerging players

  • Cure Forward: Cure Forward is a patient engagement platform focused on connecting cancer patients to clinical trials and treatment information. It overlaps with Rabble's oncology patient education and clinical trial recruitment capabilities but with a narrower scope.
  • Castor: Castor offers a decentralized clinical trial platform with eConsent, eCOA, and patient engagement features. It is comparable to Rabble's Monarch/myRabble combination for clinical trial sponsors but focused on the trial-conduct stage rather than commercial lifecycle.

Broad incumbents

  • PatientPoint: PatientPoint is a leading patient engagement platform focused on point-of-care education and communication. It shares the patient engagement and education thesis with myRabble, though it is anchored to clinical settings rather than the full care journey.
  • IQVIA (Patient Engagement & RWE): IQVIA is a global CRO and RWE leader offering patient engagement, real-world data, and commercial services to life sciences. It is a broad incumbent whose patient engagement and RWE offerings compete with Rabble's enterprise life sciences GTM.
  • Health Catalyst: Health Catalyst is a healthcare data and analytics platform providing real-world data and outcomes measurement to providers and life sciences. It is a broad incumbent competitor to Monarch's RWE and outcomes analytics positioning.
  • Medidata (Dassault Systèmes): Medidata is the largest clinical trial technology platform, offering patient engagement, RWE, and decentralized trial capabilities. It competes with Rabble for pharma RWE and trial optimization budgets at a much larger scale and broader portfolio.

Direct peers

  • Navigating Cancer: Navigating Cancer provides a patient-facing platform for oncology symptom management, treatment adherence, and care coordination, with a direct-to-patient and provider model. It is the closest pure-oncology analog to myRabble's cancer-care engagement focus.
  • Signant Health: Signant Health provides patient engagement, eCOA, and real-world evidence solutions for clinical trials and commercial pharma. It directly overlaps with Rabble's myRabble and Monarch platforms in serving life sciences with patient-centric data and engagement tooling.
  • Evidation Health: Evidation Health operates a direct-to-patient platform for real-world health data and engagement, partnering with life sciences for RWE and outcomes research. Like Rabble, it captures consented longitudinal data from patients and feeds insights to pharma.
  • TrialCard: TrialCard (now part of Pharmaceutical Product Development) provides patient access, adherence and engagement solutions for pharma. It directly overlaps with myRabble's therapy adherence and patient activation capabilities for life sciences clients.

Market position

Strengths3 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Rabble Health social profiles

Digital presence

Rabble Health compliance and trust

Trust signal

Compliance1 record

Rabble Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rabble Health leadership team

Management profile

Number of profiles

Profiles14 records

Rabble Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rabble Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rabble Health

What does Rabble Health do?

Rabble Health operates a multi-platform digital health ecosystem comprising myRabble (a patient decision and support platform that helps patients understand conditions, navigate treatment decisions, and track milestones and symptoms), Monarch (an insights and analytics platform that serves as a data integration layer to capture real-world evidence within weeks), and ClinEx (a clinical decision support platform for healthcare providers, coming soon). These platforms are designed to reduce patient drop-off across the cancer and chronic disease care journey and are sold primarily to life sciences companies, healthcare organizations, and patient advocacy organizations.

Is Rabble Health a public or private company?

Rabble Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Rabble Health founded?

Rabble Health was founded in 2020. It employs 1 to 10 people.

Where is Rabble Health based?

Rabble Health is headquartered in Thousand Oaks, United States, in the North America region.

How does Rabble Health make money?

Three revenue lines are on record. Platform Subscriptions for Life Sciences are the primary driver. The others are consulting & Implementation Services and patient Community & Engagement Services.

Who are Rabble Health's main competitors?

Emerging players on record are Cure Forward and Castor. Broad incumbents are PatientPoint, IQVIA (Patient Engagement & RWE), Health Catalyst and Medidata (Dassault Systèmes). Direct peers are Navigating Cancer, Signant Health, Evidation Health and TrialCard.

Does Rabble Health have an API?

No public API is recorded for Rabble Health.

What industry is Rabble Health in?

Rabble Health's product category is Digital Health Patient Engagement Platforms. Its primary akta.pro industry code is HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated), with a secondary code of HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 513210 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireRabbleHealth Adds Deanna Darlington to Advisory BoardRabbleHealth, a digital patient engagement company focused on cancer care, announced the appointment of Deanna Darlington to its Advisory Board. Darlington brings over 25 years of experience in government affairs, patient advocacy, and policy reform, previously serving at Amgen and founding Links2Equity in 2021 to address health disparities across underrepresented communities. The company stated the appointment will support its myRabble platform in advancing health equity and improving patient access to quality cancer care.PR NewswireRabbleHealth Welcomes Andre Player to its Advisory BoardRabbleHealth, a digital patient engagement company focused on cancer, announced the appointment of Andre Player, a veteran technology professional with 30 years of industry experience, to its Advisory Board. Player currently serves as Vice President of Strategic Alliances for Valorem Reply and has previously worked with Microsoft, Informix Software, and IBM. The company is currently closing its seed round and its myRabble platform aims to help cancer patients personalize their care by creating and connecting with their care team.PR NewswireRabbleHealth Appoints J. Michael Sprafka to Advisory BoardRabbleHealth has appointed epidemiologist J. Michael Sprafka to its Advisory Board to support its evidence-based approach to cancer patient engagement and precision medicine. This strategic move aims to leverage deidentified data through the myRabble platform to improve outcomes for patients, while the company is simultaneously closing its seed funding round.PR NewswirePrecision Medicine Marketing Veteran Diana Porter Bodden joins Rabble Health Board of AdvisorsRabble Health has appointed Diana Porter Bodden, a marketing veteran in oncology biotech and diagnostics, to its Board of Advisors. This appointment leverages her extensive experience in commercialization and patient engagement to support the company's myRabble platform as it scales operations. The announcement coincides with Rabble Health closing its seed funding round.PR NewswireRabbleHealth Appoints Former Kaiser Permanente Executive Mitch Ross to Advisory BoardRabbleHealth announced the appointment of Mitch Ross, former Vice President of Individual and Family Plans at Kaiser Permanente, to its Advisory Board. Ross brings 35 years of healthcare executive experience, having previously held leadership roles at Blue Shield of California and CareAmerica Health Plans. The digital patient engagement company, which offers the myRabble patient navigation platform for cancer care, is currently closing its first round of seed funding.PR NewswireWest Cancer Center, Memphis Breast Cancer Consortium And Rabble Health Announce Initial Results Of Care Pathway InitiativeResults from a partnership between West Cancer Center & Research Institute, Memphis Breast Cancer Consortium, and Rabble Health to address breast cancer care disparities for Black women in Memphis were announced, with the program sponsored by Amgen. Rabble Health conducted an assessment of 81 breast cancer patients and found that Margaret West Comprehensive Cancer Center demonstrated capabilities including same-day mammogram and biopsy services. The preliminary findings call on breast centers to measure adherence and improvements in quality measures and health literacy to address care disparities.PR NewswireRabble Health Appoints Chandra Kanive to COO, Koji Sonoda to VP Business DevelopmentRabble Health announced the appointment of Chandra Kanive as Chief Operating Officer and Koji Sonoda as Vice President of Business Development and Partnerships, both bringing over 20 years of experience in healthcare, technology, and digital health sectors. The company is preparing to launch its full product line and several new partnerships focused on enhancing patient experience, improving outcomes, and decreasing costs in cancer care. The executive additions follow Rabble's recent naming of Bluegrass Biggs as Chief Technology and Compliance Officer as the company builds its team to execute on its mission.